medline.ch Onkologie Urologische Tumoren

	Association between sunlight exposure and risk of prostate cancer: a systematic review and meta-analysis. Eur J Public Health Yoon JG, Kim HB. PMID: 33969413 [PubMed - as supplied by publisher]
	Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma. Front Mol Biosci Zhan C, Wang Z, Xu C, Huang X, Su J, Chen B, Wang M, Qi Z, Bai P. PMID: 33968978 [PubMed]
	The Effect of Local Therapy on M1c Prostate Cancer Patients: A Systematic Review and Meta-Analysis. Front Surg Wang Z, Cao D, Wei W. PMID: 33968976 [PubMed]
	The Heterogeneous Metabolic Patterns of Ganglia in ⁶⁸Ga-PSMA, ¹¹C-choline, and ¹⁸F-FDG PET/CT in Prostate Cancer Patients. Front Oncol Shi Y, Wu JG, Xu L, Zhu Y, Wang Y, Huang G, Liu J, Chen R. PMID: 33968772 [PubMed]
	Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice. Front Oncol Roberto M, Botticelli A, Panebianco M, Aschelter AM, Gelibter A, Ciccarese C, Minelli M, Nuti M, Santini D, Laghi A, Tomao S, Marchetti P. PMID: 33968762 [PubMed]
	A Non-Invasive Scoring System to Differential Diagnosis of Clear Cell Renal Cell Carcinoma (ccRCC) From Renal Angiomyolipoma Without Visible Fat (RAML-wvf) Based on CT Features. Front Oncol Wang XJ, Qu BQ, Zhou JP, Zhou QM, Lu YF, Pan Y, Xu JX, Miu YY, Wang HQ, Yu RS. PMID: 33968732 [PubMed]
	The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma. Front Oncol Zhou Y, Wang X, Zhang W, Liu H, Liu D, Chen P, Xu D, Liu J, Li Y, Zeng G, Li M, Wu Z, Zhang Y, Wang X, DiSanto ME, Zhang X. PMID: 33968730 [PubMed]
	Extracellular vesicles in prostate cancer: a narrative review. Transl Androl Urol Hatano K, Fujita K. PMID: 33968677 [PubMed]
	Urinary extracellular vesicles: a rising star in bladder cancer management. Transl Androl Urol Urabe F, Kimura T, Ito K, Yamamoto Y, Tsuzuki S, Miki J, Ochiya T, Egawa S. PMID: 33968676 [PubMed]
	Narrative review of urinary glycan biomarkers in prostate cancer. Transl Androl Urol Hatakeyama S, Yoneyama T, Tobisawa Y, Yamamoto H, Ohyama C. PMID: 33968674 [PubMed]
	Application of metastatic biopsy based on "When, Who, Why, Where, How (4W1H)" principle in diagnosis and treatment of metastatic castration-resistance prostate cancer. Transl Androl Urol Liu Z, Wang L, Zhou Y, Wang C, Ma Y, Zhao Y, Tian J, Huang H, Wang H, Wang Y, Niu Y. PMID: 33968660 [PubMed]
	Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol Focus Lardas M, Grivas N, Debray TPA, Zattoni F, Berridge C, Cumberbatch M, Van den Broeck T, Briers E, De Santis M, Farolfi A, Fossati N, Gandaglia G, Gillessen S, O'Hanlon S, Henry A, Liew M, Mason M, Moris L, Oprea-Lager D, Ploussard G, Rouviere O, Schoots IG, van der Kwast T, van der Poel H, Wiegel T, Willemse PP, Yuan CY, Grummet JP, Tilki D, van den Bergh RCN, Lam TB, Cornford P, Mottet N. PMID: 33967010 [PubMed - as supplied by publisher]
	Digital Medicine in Men with Advanced Prostate Cancer - A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment. Clin Oncol (R Coll Radiol) Appleyard SE, Larkin MJW, Stewart EM, Minton O, Gilbert DC. PMID: 33966948 [PubMed - as supplied by publisher]
	Validation of the COBRA nomogram for the prediction of cancer specific survival in patients treated with radical cystectomy for bladder cancer: An international wide cohort study. Eur J Surg Oncol De Nunzio C, Franco A, Simone G, Tuderti G, Anceschi U, Brassetti A, Daneshmand S, Miranda G, Desai MM, Gill I, Abol-Enein H, Molinaro E, Nacchia A, Lombardo R, Leonardo C, Tubaro A. PMID: 33966945 [PubMed - as supplied by publisher]
	Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: The Triumph of Radiobiology. Rev Recent Clin Trials Kougioumtzopoulou A, Platoni K, Zygogianni A, Kounadis G, Syrigos KN, Psyrri A, Bamias A, Kelekis N, Kouloulias V. PMID: 33966623 [PubMed - as supplied by publisher]
	The prognostic value of sarcopenia in patients with prostate cancer: a systematic review. Curr Opin Urol Jahrreiss V, Laukhtina E, D'Andrea D, Shariat SF. PMID: 33965982 [PubMed - as supplied by publisher]
	Part I. Health-related quality of life in bladder cancer patients: general and cancer-specific instruments. Curr Opin Urol Zimmermann K, Mostafaei H, Heidenreich A, Schmelz HU, Shariat SF, Mori K. PMID: 33965980 [PubMed - as supplied by publisher]
	Adverse events of systemic immune-based combination therapies in the first-line treatment of patients with metastatic renal cell carcinoma: systematic review and network meta-analysis. Curr Opin Urol Quhal F, Mori K, Remzi M, Fajkovic H, Shariat SF, Schmidinger M. PMID: 33965978 [PubMed - as supplied by publisher]
	Phase I trial of intravesical Bacillus Calmette-GuÃ©rin combined with intravenous pembrolizumab in recurrent or persistent high-grade non-muscle-invasive bladder cancer after previous Bacillus Calmette-GuÃ©rin treatment. World J Urol Alanee S, Sana S, El-Zawahry A, Peabody J, Pearce T, Adams N, Deebajah M, Crabtree J, Delfino K, McVary K, Robinson K, Rao K. PMID: 33966128 [PubMed - as supplied by publisher]
	Emerging roles of cancer-testis antigenes, semenogelin 1 and 2, in neoplastic cells. Cell Death Discov Shuvalov O, Kizenko A, Petukhov A, Fedorova O, Daks A, Barlev N. PMID: 33966049 [PubMed]

Artikel 1 - 20 / 135442

Seite 1 von 6773

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung